Synapse - Vicky Makker

Search Within

Vicky Makker

Results (267)

Modern associations of uterine carcinomas with prior exposure to tamoxifen

Meeting Abstract

Rios-Doria, E.; Hodgson, A.; Aviki, E.; Zivanovic, O.; Friedman, C.; Aghajanian, C.; Makker, V.; Liu, Y.; Zamarin, D.; Leitao, M.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Germline drivers of gynecologic carcinosarcoma

Meeting Abstract

Sia, T.; Birsoy, O.; Kemel, Y.; Maio, A.; Salo-Mullen, E.; Sheehan, M.; Hensley, M.; Rubinstein, M.; Makker, V.; Grisham, R.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

ENGOT-EN20/GOG-3083/XPORT-EC-042 A phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients (pts) with P53 wild-type, advanced or recurrent endometrial carcinoma

Meeting Abstract

Makker, V.; Vergote, I.; Mirza, M.; Coleman, R.; Fidalgo, J. A. P.; Monk, B.; Valabrega, G.; Slomovitz, B.; van Gorp, T.; Moore, K.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Characterization of tumor response with lenvatinib plus pembrolizumab in study 309/KEYNOTE-775

Meeting Abstract

Makker, V.; Lorusso, D.; Moore, R.; Miller, D.; Mackay, H.; Santin, A.; Ushijima, K.; Kim, Y. M.; Sanli, U.; Yonemori, K.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Real-world outcomes and adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer

Meeting Abstract

Zammarrelli, W.; Ma, W.; Espino, K.; Yeoshoua, E.; Ehmann, S.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N.; Aghajanian, C.; Green, A.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Isolated vaginal recurrence in women with stage I endometrial cancer

Journal Article

Rios-Doria, E.; Cun, H. T.; Filippova, O. T.; Mueller, J. J.; Alektiar, K. M.; Ellenson, L. H.; Makker, V.; Lakhman, Y.; Leitao, M. M. Jr; Jhingran, A.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer

Journal Article

Han, S. N.; Oza, A.; Colombo, N.; Oaknin, A.; Raspagliesi, F.; Wenham, R. M.; Braicu, E. I.; Jewell, A.; Makker, V.; Krell, J.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer

Journal Article

Zammarrelli, W. A. 3rd; Ma, W.; Espino, K.; Gordhandas, S.; Yeoshoua, E.; Ehmann, S.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N. R.; Aghajanian, C.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

ENGOT-EN20/GOG-3083/xport-EC-042: A phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with P53 wild-type, advanced or recurrent endometrial carcinoma

Meeting Abstract

Vergote, I.; Mirza, M. R.; Coleman, R. L.; Perez-Fidalgo, J. A.; Monk, B. J.; Valabrega, G.; Slomovitz, B. M.; Van Gorp, T.; Moore, K. N.; Sehouli, J.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Long-term follow up of selinexor maintenance in patients with TP53 wt advanced or recurrent endometrial cancer: A pre-specified subgroup analysis from the phase 3 ENGOT-EN5/GOG-3055/SIENDO study

Meeting Abstract

Slomovitz, B. M.; Perez-Fidalgo, J. A.; Hamilton, E. P.; Valabrega, G.; Van Gorp, T.; Sehouli, J.; Klat, J.; Levy, T.; Welch, S.; Richardson, D. L.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save